DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial (ATN)

June 2, 2023 updated by: DePuy Orthopaedics

Clinical Trial to Monitor the Clinical Effectiveness of the DePuy ATN Trochanteric Nailing System in the Treatment of Trochanteric Fractures of the Proximal Femur

The purpose of this study is to monitor trochanteric fracture healing and review the performance of the ATN system.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Proximal femoral fractures are among the most common femoral fractures. In the past plates and screws were often used to repair these fractures but this treatment had limitations including restricted weight bearing. Intermedullary nailing is an alternative to plate and screw treatment. Weight bearing is allowed and the procedure can be a less invasive. Among intramedullary nailing complications are iatrogenic fractures that can be further divided into trochanteric and femoral shaft fractures. Trochanteric fractures often heal without additional intervention however femoral shaft fractures usually require an additional surgical procedure to facilitate healing. This study will monitor fracture healing using clinical and radiographic evaluations of subjects with trochanteric fractures of the proximal femur treated with the ATN system.

Study Type

Observational

Enrollment (Actual)

62

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Colorado Springs, Colorado, United States, 80910
        • Front Range Orthopaedics
      • Englewood, Colorado, United States, 80110
        • Orthopaedic Physicians of Colorado
    • New York
      • Buffalo, New York, United States, 14215
        • Erie County Medical Center
    • North Carolina
      • Asheville, North Carolina, United States, 28801
        • Blue Ridge Bone and Joint

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ability to understand and willing to sign the approved consent form.
  • 18 years of age
  • Skeletally mature
  • Have stable or unstable proximal femur fracture, including pertrochanteric, intertrochanteric, high subtrochanteric or any combination of the AO Proximal Femur Fracture Classification

Exclusion Criteria:

  • Subjects with concomitant lower extremity injuries or multiple trauma that would interfere with normal hip fracture rehabilitation.
  • Subjects who have isolated or combined medial femoral neck fractures.
  • Subjects who are unwilling or unable to comply with a rehabilitation program or are unwilling or unable to be assessed for 1 year following surgery.
  • Subjects who are pregnant or breastfeeding.
  • Subjects who are a prisoner or a known alcohol or drug abuser.
  • Subjects who have a prior surgical history in the affected hip, or conditions that may interfere with outcome or impede healing.
  • Subjects who have an obliterated medullary canal or other conditions that may complicate the reaming process.
  • Subjects who have evidence of active untreated infections that may spread to other areas of the body.
  • Subjects who have a highly communicable disease or pathology that may limit follow-up.
  • Subjects, who in the opinion of the Clinical Investigator, have an existing condition that indicates the Subject is not a good candidate for the study.
  • Subjects who are participating in another clinical investigation.
  • Subjects known to have allergies to titanium, aluminum, vanadium.
  • Subjects who are currently eligible for workman's compensation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
A
Monitoring of trochanteric fractures after treatment with the ATN system.
Trochanteric nailing for proximal femoral fractures.
Other Names:
  • Ace Trochanteric Nail (ATN) system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success in Terms of the Merle D'Aubigne Postel Score for Pain Category
Time Frame: 4 weeks, 3, 6 and 12 months
Merle D'Aubigne measures three categories for Pain, Mobility and Ability to walk using a 0 to 6 scoring scale for each category. Scoring is 0 indicating worse outcomes and 6 indicating better outcomes. Each Category is scored and reported separately
4 weeks, 3, 6 and 12 months
Success in Terms of the Merle D'Aubigne Postel Score for Walk Category
Time Frame: 4 weeks, 3, 6 and 12 months
Merle D'Aubigne measures three categories for Pain, Mobility and Ability to walk using a 0 to 6 scoring scale for each category. Scoring is 0 indicating worse outcomes and 6 indicating better outcomes. Each Category is scored and reported separately
4 weeks, 3, 6 and 12 months
Success in Terms of the Merle D'Aubigne Postel Score for Mobility Category
Time Frame: 4 weeks, 3, 6 and 12 months
Merle D'Aubigne measures three categories for Pain, Mobility and Ability to walk using a 0 to 6 scoring scale for each category. Scoring is 0 indicating worse outcomes and 6 indicating better outcomes. Each Category is scored and reported separately
4 weeks, 3, 6 and 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Lower Extremity Measure (LEM)
Time Frame: 4 weeks, 3, 6 and 12 months
4 weeks, 3, 6 and 12 months
Medical Imaging
Time Frame: 4 weeks, 3, 6 and 12 months
4 weeks, 3, 6 and 12 months
Six Item Screener and Ambulatory Status
Time Frame: 4 weeks, 3, 6 and 12 months
4 weeks, 3, 6 and 12 months
SF-12
Time Frame: 4 weeks, 3, 6 and 12 months
4 weeks, 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sam Himden, DePuy Orthopaedics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2006

Primary Completion (Actual)

September 1, 2009

Study Completion (Actual)

September 1, 2009

Study Registration Dates

First Submitted

October 17, 2007

First Submitted That Met QC Criteria

October 18, 2007

First Posted (Estimated)

October 19, 2007

Study Record Updates

Last Update Posted (Actual)

June 6, 2023

Last Update Submitted That Met QC Criteria

June 2, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoral Fracture (Proximal)

Clinical Trials on Intramedullary nailing

3
Subscribe